PCSA · Processa Pharmaceuticals, Inc. · Documents
$1.81
-0.05 (-2.69%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 14, 2026
The latest filing states the doubt was alleviated.
“Following our acquisition of Vidya and closing of the related $200 million gross private placement (from which we received net proceeds of $183.3 million) on July 30, 2026, we believe our cash and cash equivalents will be sufficient to satisfy our cash requirements over the next 12 months and beyond. This represents a material change from what we reported in our 2025 Form 10-K that disclosed substantial doubt of our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$5.06M
Shares
2.79M
Volume · Oct 23
35.05K
Avg daily vol (3M)
266.29K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-10-02 | — | |
| 8-K | — | 2024-08-28 | — | |
| 10-Q | — | 2024-08-13 | 2024-06-30 | |
| 8-K | — | 2024-07-30 | — | |
| 8-K | — | 2024-07-17 | 2024-07-16 | |
| 8-K | — | 2024-07-02 | 2024-06-28 | |
| DEFR14A | — | 2024-06-11 | — | |
| S-3 | — | 2024-05-21 | — | |
| 8-K | — | 2024-05-21 | — | |
| 10-Q | — | 2024-05-10 | 2024-03-31 | |
| DEF 14A | — | 2024-04-29 | — | |
| DEFA14A | — | 2024-04-29 | — | |
| 8-K | — | 2024-04-11 | — | |
| 8-K | — | 2024-04-04 | 2024-04-03 | |
| 10-K | — | 2024-03-29 | 2023-12-31 | |
| 8-K | — | 2024-02-21 | 2024-02-20 | |
| 8-K | — | 2024-02-06 | — | |
| 8-K | — | 2024-01-30 | 2024-01-26 | |
| 8-K | — | 2024-01-25 | — | |
| S-1/A | — | 2024-01-22 | — | |
| 8-K | — | 2024-01-19 | — | |
| 8-K | — | 2024-01-18 | — | |
| 8-K | — | 2024-01-08 | — | |
| S-1 | — | 2023-12-29 | — | |
| 8-K | — | 2023-12-19 | — | |
| 8-K | — | 2023-12-05 | — | |
| 8-K | — | 2023-11-16 | — | |
| 8-K | — | 2023-11-15 | 2023-11-14 | |
| 10-Q | — | 2023-11-13 | 2023-09-30 | |
| 8-K | — | 2023-11-13 | 2023-11-09 | |
| 8-K | — | 2023-10-16 | — | |
| DEF 14A | — | 2023-10-05 | — | |
| DEFA14A | — | 2023-10-05 | — | |
| PRE 14A | — | 2023-09-25 | — | |
| 8-K | — | 2023-09-21 | 2023-09-18 | |
| 8-K | — | 2023-08-17 | — | |
| 10-Q | — | 2023-08-10 | 2023-06-30 | |
| 8-K | — | 2023-08-08 | — | |
| 8-K | — | 2023-06-29 | 2023-06-27 | |
| 8-K | — | 2023-06-21 | — | |
| 8-K | — | 2023-05-24 | — | |
| 8-K | — | 2023-05-18 | — | |
| 10-Q | — | 2023-05-15 | 2023-03-31 | |
| 8-K | — | 2023-05-08 | 2023-05-06 | |
| DEFA14A | — | 2023-05-01 | — | |
| ARS | — | 2023-05-01 | 2022-12-31 | |
| DEF 14A | — | 2023-05-01 | — | |
| PRE 14A | — | 2023-04-14 | — | |
| 8-K | — | 2023-03-31 | 2023-03-30 | |
| 10-K | — | 2023-03-30 | 2022-12-31 |
Showing 51–100 of 174 filings